Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.
This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.